Literature DB >> 24577681

Clinical approach to the patient with a solid pancreatic mass.

Reinhold Függer1, Odo Gangl, Uwe Fröschl.   

Abstract

Diagnosis and clinical work-up of a solid pancreatic mass is a challenging problem. Patients' history, laboratory parameters, computed tomography magnetic resonance imaging, and endosonography are the cornerstones in diagnosis. Biopsy is indicated in selected patients. The main goal of surgical indication is to select patients with suspected malignancy who are resectable, but avoid unnecessary resections. About 5 % of patients resected due to suspicion of malignancy finally present with a benign histology. Autoimmune pancreatitis is the most frequent cause of such unnecessary resections.

Entities:  

Mesh:

Year:  2014        PMID: 24577681     DOI: 10.1007/s10354-014-0266-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  40 in total

1.  Hospital volume and surgical mortality in the United States.

Authors:  John D Birkmeyer; Andrea E Siewers; Emily V A Finlayson; Therese A Stukel; F Lee Lucas; Ida Batista; H Gilbert Welch; David E Wennberg
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

2.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

3.  A matched case-control study of preoperative biliary drainage in patients with pancreatic adenocarcinoma: routine drainage is not justified.

Authors:  James J Mezhir; Murray F Brennan; Raymond E Baser; Michael I D'Angelica; Yuman Fong; Ronald P DeMatteo; William R Jarnagin; Peter J Allen
Journal:  J Gastrointest Surg       Date:  2009-09-23       Impact factor: 3.452

4.  Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas.

Authors:  S Fritz; T Hackert; U Hinz; W Hartwig; M W Büchler; J Werner
Journal:  Br J Surg       Date:  2010-10-14       Impact factor: 6.939

Review 5.  [PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Authors:  K Scheidhauer; M Miederer; F C Gaertner
Journal:  Radiologe       Date:  2009-03       Impact factor: 0.635

6.  Radical pancreatoduodenectomy for misdiagnosed pancreatic mass.

Authors:  C D Smith; K E Behrns; J A van Heerden; M G Sarr
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

Review 7.  Preoperative tissue diagnosis for tumours of the pancreas.

Authors:  W Hartwig; L Schneider; M K Diener; F Bergmann; M W Büchler; J Werner
Journal:  Br J Surg       Date:  2009-01       Impact factor: 6.939

8.  A prospective evaluation of an algorithm incorporating routine preoperative endoscopic ultrasound-guided fine needle aspiration in suspected pancreatic cancer.

Authors:  Mohamad A Eloubeidi; Shyam Varadarajulu; Shilpa Desai; Rhett Shirley; Martin J Heslin; Mohit Mehra; Juan P Arnoletti; Isam Eltoum; Charles M Wilcox; Selwyn M Vickers
Journal:  J Gastrointest Surg       Date:  2007-07       Impact factor: 3.452

Review 9.  Pancreatic cancer--EUS and early diagnosis.

Authors:  Lars Helmstaedter; Juergen Ferdinand Riemann
Journal:  Langenbecks Arch Surg       Date:  2008-02-05       Impact factor: 3.445

10.  EUS-guided tissue sampling: comparison of "dual sampling" (Trucut biopsy plus FNA) with "sequential sampling" (Trucut biopsy and then FNA as required).

Authors:  G P Aithal; G K Anagnostopoulos; W Tam; J Dean; A Zaitoun; G Kocjan; K Ragunath; S P Pereira
Journal:  Endoscopy       Date:  2007-07-10       Impact factor: 10.093

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.